Attached files

file filename
EX-32 - EXHIBIT 32.1 - REGAL ONE Corpexhibit321.htm
EX-31 - EXHIBIT 31.1 - REGAL ONE Corpexhibit311.htm



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 


ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2013

 


Commission File Number 814-00710

 

REGAL ONE CORPORATION

(Exact name of Registrant as specified in its charter)

 

          Florida                                 95-4158065

(State or other jurisdiction of       (I.R.S. employer identification No.)

incorporation or organization)

 

P.O. Box 25610,

Scottsdale, AZ                                    85255-0110

(Address of principal executive offices)                (Zip code)

 

Registrant's telephone number, including area code: (310) 312-6888

 

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

 

Title of Each Class                        Name of Each Exchange on

                                               Which Registered

Common Stock, par value $.001 per share       OTC Bulletin Board



Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes []  No [X]

 

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes []  No [X]


Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes [X]  No []


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No []


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (Sec. 229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. []


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of accelerated filer, large accelerated filer and smaller reporting company in rule 12b-2 of the Exchange Act. (Check one.)

    Large accelerated filer  []      Accelerated filer []

    Non Accelerated filer    [X]     Smaller Reporting Company []

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes [] No [X]


The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant was approximately $119,303 computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity on the over-the-counter pink sheet market (OTC Pink Sheets), as of the last business day of the registrant's most recently completed second fiscal quarter.


As of March 31, 2014, there were: 3,633,067 shares of common stock, $.001 par value, issued and outstanding; and 100,000 shares of Series B convertible preferred stock outstanding. The outstanding Series B convertible preferred stock is convertible into an aggregate of 10,000,000 shares of common stock.






























                            TABLE OF CONTENTS



                                                                        Page

                                    PART I

ITEM 1.     Business                                                       4

Item 1A.    Risk Factors                                                 8-13

Item 1B.    Unresolved Staff Comments                                     14

Item 2.     Properties                                                    14

Item 3.     Legal Proceedings                                             14

Item 4.     Mine Safety Disclosures                                       14


                                    PART II

Item 5.     Market for Registrant's Common Equity, Related Stockholder

              Matters and Issuer Purchases of Equity Securities           15

Item 6.     Selected Financial Data                                       17

Item 7.     Management's Discussion and Analysis of Financial Condition

                And Results of Operations                                 18

Item 7A.    Quantitative and Qualitative Disclosures about Market Risk    22

Item 8.     Financial Statements and Supplementary Data                   22

Item 9.     Changes in and Disagreements with Accountants on Accounting

                And Financial Disclosure                                  23

Item 9A.    Controls and Procedures                                       23

Item 9B.    Other Information                                             24


                                   PART III

Item 10.    Directors, Executive Officers and Corporate Governance        25

Item 11.    Executive and Director Compensation                           27

Item 12.    Security Ownership of Certain Beneficial Owners and

                 Management and Related Stockholder Matters               28

Item 13.    Certain Relationships and Related Transactions, and Director

                 Independence                                             29

Item 14.    Principal Accountant Fees and Services                        29


                                   PART IV


Item 15.    Exhibits and Financial Statement Schedules                    30


Signatures                                                                31

Report of Independent Registered Public Accounting Firm                   F1

Financial Statement Schedules                                          F2-F8

Notes to Financial Statements                                          41-49













                                  PART I

 

FORWARD LOOKING STATEMENTS


This annual report contains statements, referred to as "forward-looking statements", "within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are intended to convey our expectations or predictions regarding the occurrence of possible future events or the existence of trends and factors that may impact our future plans and operating results. These forward-looking statements are derived, in part, from various assumptions and analysis we have made in the context of our current business plan and information currently available to use and in light of our experience and perceptions of historical trends, current conditions and expected future developments and other factors we believe are appropriate in the circumstances. You can generally identify forward looking statements through words and phrases such as "believe", "expect", "seek", "estimate", "anticipate", "intend", "plan", "budget", "project", "may likely result", "may be", "may continue" and other similar expressions. When reading any forward-looking statement you should remain mindful that actual results or developments may vary substantially from those expected as expressed in or implied by that statement for a number of reasons or factors, including but not limited to:

  

     The type and character of our future investments

 

     Future sources of revenue and/or income


     Increases in operating expenses

 

     Future trends with regard to net investment losses


     How long cash and assets on hand can sustain our operations.


     Other statements regarding our future operations, financial condition and

     prospects and business strategies.

 

These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward-looking statements. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements. Given these risks and uncertainties, investors, prospective investors, and readers are cautioned not to place undue reliance on such forward-looking statements. See Item 1A - Risk Factors.


DESCRIPTION OF BUSINESS


Overview


Regal One Corporation (Regal, or the Company) is a financial services company which coaches and assists biomedical companies, through our network of professionals, in listing their securities usually on the over-the-counter pink sheet market. Since inception we have been involved in a number of industries.


Regal was initially incorporated in 1959 as Electro-Mechanical Services Inc., in the state of Florida. In 1998 we changed our name to Regal One Corporation. On March 7, 2005, our Board of Directors determined it was in our shareholders' best interest to change the focus of the company's operation to providing financial services through our network of advisors and professionals.


Typically these services are provided to early stage biomedical companies who can benefit from our managerial skills, network of professional consultants and other partners.


During our clients' early stage of development, they typically have limited resources and may compensate us for our services in capital stock. Accordingly, although our primary business is to provide consulting services and not to be engaged in the business of investing, reinvesting, owning, holding or trading in securities, we may nonetheless be considered an investment company as that term is defined in the Investment Company Act of 1940 (1940 Act). In order to lessen the regulatory restrictions associated with the requirements of the 1940 Act, on June 16, 2005 we elected to be treated as a Business Development Company (BDC) in accordance with sections 55 through 65 of the 1940 Act.


Pursuant to the requirements of the Investment Company Act of 1940, as amended, the Board of Directors is responsible for determining in good faith the fair value of the securities and assets held by the Company. The Investment Committee of the Board of Directors bases its determination on, among other things, applicable quantitative and qualitative factors. These factors may include, but are not limited to, the type of securities, the nature of the business of the portfolio company, the marketability of the valuation of securities of publicly traded companies in the same or similar industries, current financial conditions and operating results of the portfolio company, sales and earnings growth of the portfolio company, operating revenues of the portfolio company, competitive conditions, and current and prospective conditions in the overall stock market. Without a readily recognized market value, the estimated value of some portfolio securities may differ significantly from the values that would be placed on the portfolio should there be a ready market for such equity securities currently in existence.


Where the stock market has established a trading history and sufficient volume to provide a fair market value price for the securities held by our Company as saleable current assets, we will value those securities at the closing price per share as of the last day of the fiscal period being reported.


Strategy


We intend to focus our efforts on assisting private biomedical companies with distinctive IP and well-defined, near-term applications that address significant and quantifiable markets and that can benefit from our network of business professionals. Our Investment Committee has adopted a charter wherein these criteria will be weighed against other criteria including:


     Strategic fit,

     Management ability, and

     Incremental value that we can bring to the potential client.


The potential client must also be willing to comply with the Company's requirement as a BDC to offer significant managerial oversight and guidance, including the right of the Company to a seat on the client's board of directors.


To date we have secured our clients through word of mouth or industry referrals from lawyers, accountants and other professionals. In looking at prospective clients, we do not focus on any particular geographic region and would consider clients globally.




Portfolio Investments


Our investment portfolio is summarized as follows:

                                                           Carrying Value

Name of Company                        Investment        of Investment as of

                                                            Dec. 31, 2013

 

Neuralstem, Inc. (OTCBB: CUR)            Common Stock        $   611,100 (1)

Neuralstem, Inc.                         Warrant                 513,000 (1)

Western Asset Money Market Fund          Money Market Fund        14,615  

Rampart Detections Systems Ltd.          Common Stock              1,200 (2)

                                                              -----------

Total                                                        $ 1,139,515


See also Schedule F-3 Schedule of Investments and Note 4 Investments in Notes to Financial Statements.


(1) At December 31, 2013, we held 210,000 shares of Neuralstem, Inc. common stock and warrants to purchase an additional 1,000,000 shares of common stock at a price of $5.00 per share.


(2) The Company has an investment in the common stock of Rampart Detection Systems Ltd.


Employees


We have one part-time employee. We expect to use consultants, attorneys, and accountants as necessary and we do not anticipate a need to engage any additional full-time employees as long as business needs are being identified and evaluated. The need for employees and their availability will be addressed in connection with a decision concerning whether or not to acquire or participate in a specific business venture.


Compliance with Business Development Company Reporting Requirements

 

The Board of Directors of the Company, comprising a majority of Independent Directors, adopted in March 2006 a number of resolutions, codes and charters to complete compliance with BDC operating requirements prior to reporting as a BDC. These include establishing Board committees for Audit, Nominating, Compensation, Investment, and Corporate Governance, and adopting a Code of Ethics, an Audit Committee Charter and an Investment Committee Charter.


Code of Ethics:


The Code of Ethics in general prohibits any officer, director or advisory person (collectively, "Access Person") of the Company from acquiring any interest in any security which the Company (i) is considering a purchase or sale thereof,  (ii) is being purchased or sold by the Company, or (iii) is being sold short by the Company.  The Access Person is required to advise the Company in writing of his or her acquisition or sale of any such security. The Company's Code of Ethics is posted on our website at http://www.regal1.com/.


Audit Committee:


The primary responsibility of the Audit Committee is to oversee the Company's financial reporting process on behalf of the Company's Board of Directors and report the result of its activities to the Board. Such responsibilities shall include but not be limited to the selection, and if necessary, the replacement of the Company's independent registered public accounting firm; the review and discussion with such independent registered public accounting firm and the Company's internal audit department of (i) the overall scope and plans for the audit, (ii) the adequacy and effectiveness of the accounting and financial controls, including the Company's system to monitor and manage business risks, and legal and ethical programs, and (iii) the results of the annual audit, including the financial statements to be included in the Company's annual report on Form 10-K.


The Company's Audit Committee and Compensation Committee are comprised of one director. We anticipate that additional board members will be admitted and will augment the current audit committee. In January 2009, Mr. Bernard L. Brodkorb was accepted as a Regal Board Member and Director. Mr. Brodkorb is a licensed Certified Public Accountant (CPA) who is a qualified financial expert and will be actively participating on the Audit Committee.


Investment Committee: The Investment Committee shall have oversight responsibility with respect to reviewing and overseeing the Company's contemplated investments and portfolio companies on behalf of the Board and shall report the results of their activities to the Board.  Such Investment Committee shall (i) have the ultimate authority for and responsibility to evaluate and recommend investments, and (ii) review and discuss with management (a) the performance of portfolio companies, (b) the diversity and risk of the Company's investment portfolio, and, where appropriate, make recommendations respecting the role, divestiture or addition of portfolio investments and (c) all solicited and unsolicited offers to purchase portfolio company positions.


Compliance with the Sarbanes-Oxley Act of 2002


The Sarbanes-Oxley Act of 2002 imposes a wide variety of new regulatory requirements on publicly held companies and their insiders.  Many of these requirements will affect us in the following ways:  For example:


Our chief executive officer and chief financial officer must certify the accuracy of the financial statements contained in our periodic reports;


Our periodic reports must disclose our conclusions about the effectiveness of our controls and procedures and whether there were significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.


We are required to review our current policies and procedures to determine whether we comply with the Sarbanes-Oxley Act and the new regulations promulgated within the regulations stated in the act.


We will continue to monitor our compliance with all future regulations that are adopted or required under the Sarbanes-Oxley Act and will take actions necessary to ensure we are in compliance therewith.




Item 1A. RISK FACTORS


The purchase of shares of capital stock of the Company involves many risks. A prospective investor should carefully consider the following factors before making a decision to purchase any such shares:


 

The Company Has Historically Lost Money and Losses May Continue in the Future:


Except for 2013 and 2009 when the Company booked a net operating gain of 707,991 and $514,737, respectively, including an unrealized appreciation in value of our common stock and stock option investments, the Company has historically lost money.  As a result, it has an accumulated deficit of $8,416,787 at December 31, 2013. For the year ended December 31, 2013 the Company had a net investment loss from operations of $111,791 excluding $819,782 in realized and unrealized gain from investments. Accordingly, the Company may experience significant liquidity and cash flow problems if we are not able to raise additional capital as needed on acceptable terms.  No assurances can be given we will be successful in reaching or maintaining profitable operations and future losses are likely to occur. The Company's investment portfolio is concentrated in one company which increases the risk of favorable investment results. These factors raise doubt about the Companys ability to continue as a going concern.


The Companys ability to continue as a going concern depends upon obtaining sufficient financing to maintain adequate liquidity until such time as operations produce positive cash flow. However, there can be no assurance these actions will be successful.


The accompanying financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. The financial statements do not include any adjustments that might result if the Company was forced to discontinue its operations.



The Company's cash expenses for operations are large relative to its cash flow which requires the Company continually to sell shares from its investments. This could result in substantial dilution to our shareholders equity and our ability to continue operations should additional capital not be raised:


For years ended December 31, 2013 and December 31, 2012 the Company had total operating expenses of $111,791 and $122,173 respectively. Consequently, the Company was required to sell shares of the Company's inventory of investment common stock to raise the cash necessary to pay ongoing expenses. The Company sold 70,000 shares of Neuralstem common stock in 2013 to finance operational costs. During 2012 it sold 20,000 shares of stock. Net proceeds from the sale of securities in 2013 amounted to $115,054. This practice is likely to continue for the foreseeable future and could lead to continuing dilution in net asset value for the Company's stockholders. Moreover, there is no assurance the Company will be able to find investors willing to purchase Company shares at a price and on terms acceptable to the Company, in which case, the Company could further deplete its cash resources.



Regulations governing operations of a business development company will affect the Company's ability to raise, and the way in which the Company raises additional capital. This could result in the Company not being able to raise additional capital and accordingly cease operations:


Under the provisions of the 1940 Act, the Company is permitted, as a business development company, to issue senior securities only in amounts such that asset coverage, as defined in the 1940 Act, equals at least 200% after each issuance of senior securities. If the value of portfolio assets declines, the Company may be unable to satisfy this test. If that happens, the Company may be required to sell a portion of its investments and, depending on the nature of the Company's leverage, repay a portion of its indebtedness at a time when such sales may be disadvantageous and result in unfavorable prices. Applicable law requires that business development companies may invest 70% of its assets only in privately held U.S. companies, small, publicly traded U.S. companies, certain high-quality debt, and cash. The Company is not generally able to issue and sell common stock at a price below net asset value per share. The Company may, however, sell common stock, or warrants, options or rights to acquire common stock, at prices below the current net asset value of the common stock if the Board of Directors determines that such sale is in the best interests of the Company and its stockholders approve such sale. In any such case, the price at which the Company's securities are to be issued and sold may not be less than a price which, in the determination of the Board of Directors, closely approximates the market value of such securities (less any distributing commission or discount)


The success of the Company will depend in part on its size, and in part on management's ability to make successful investments:


If the Company is unable to select profitable investments, the Company will not achieve its objectives. Moreover, if the size of the Company remains small, operating expenses will be higher as a percentage of invested capital than would otherwise be the case, which increases the risk of loss (and reduces the chance for gain) for investors.

 

The Company's investment activities are inherently risky:


The Company's investment activities involve a significant degree of risk. The performance of any investment is subject to numerous factors which are neither within the control of nor predictable by the Company. Such factors include a wide range of economic, political, competitive and other conditions which may affect investments in general or specific industries or companies.


The Company's equity investments may lose all or part of their value, causing the Company to lose all or part of its investment in those companies:


The equity interests in which the Company invests may not appreciate in value and may decline in value. Accordingly, the Company may not be able to realize gains from its investments and any gains realized on the disposition of any equity interests may not be sufficient to offset any losses experienced. Moreover, the Company's primary objective is to invest in early stage companies, the products or services of which will frequently not have demonstrated market acceptance. Many portfolio companies lack depth of management and have limited financial resources. All of these factors make investments in the Company's portfolio companies particularly risky.




The Company's common stock is trading at a substantial discount to net asset value:


The following table summarizes the Company's approximate net asset value per common share and corresponding stock price for the last five years:


  

As of December 31,     2013     2012     2011      2010     2009


  Net Asset Value       $0.28   $0.09     $0.10    $0.41    $0.45

 

  Stock Price*           0.04    0.07      0.06     0.06     0.03

 

*Stock Price is the closing price as of the last trading day in December of each corresponding year.

 

At present the Company is trading at a discount to Net Asset Value. In 2005, the Company's common stock traded at a substantial premium to its net asset value. Moreover, as the Company utilizes and monetizes its investment assets for its continuing operating needs the Net Asset Value may decrease, potentially affecting the price of the Company's common stock.

 

Our common stock is traded on the Over-the-Counter Bulletin Board "Pink Sheet" market, which may make it more difficult for investors to resell their shares due to suitability requirements:


Our common stock is currently traded on the Over the Counter Bulletin Board under the symbol (RONE) where we expect it to remain in the foreseeable future. Broker-dealers often decline to trade in OTC Pink Sheet stocks given the markets for such securities are often limited, the stocks are more volatile, and the risk to investors is greater. These factors may reduce the potential market for our common stock by reducing the number of potential investors. This may make it more difficult for investors in our common stock to sell shares to third parties or to otherwise dispose of their shares. This could cause our stock price to decline.


We could fail to retain or attract key personnel who are required in order for us to fully carry out our business plan:


The Company's operations and ability to implement its business plan are dependent upon the efforts of its key personnel, the loss of the services of which could have a material adverse effect on the Company. The Company will likely be required to hire additional personnel to implement its business plan. Qualified employees and consultants are in great demand and are likely to remain a limited resource for the foreseeable future. Competition for skilled, creative and technical talent is intense. There can be no assurance the Company will be successful in attracting and retaining such personnel. Any failure by the Company to retain the services of existing employees and consultants or to hire new employees when necessary could have a material adverse effect upon the Company's business, financial condition and results of operations. Our future success depends in significant part on the continued services of Charles J. Newman, our Chairman, Chief Executive Officer and CFO. We have no employment agreement with or company life insurance on Mr. Newman.


The Company operates in a highly competitive market:


The Company faces competition from a number of sources, many of which have longer operating histories, and significantly greater financial, management, marketing and other resources than the Company. The Company's ability to generate new portfolio clients depends to a significant degree on its reputation among potential clients and partners, and its ability to reach acceptable investment terms with potential clients relative to competitive alternatives. In the event that the reputation of the Company is adversely impacted, or that potential portfolio clients perceive competitive alternatives to be superior, the business, financial condition and operating results of the Company could be adversely affected.



Our officers and directors have the ability to exercise significant influence over matters submitted for stockholder approval and their interests may differ from other stockholders:


Our executive officers and directors have the ability to appoint a majority to the Board of Directors. Accordingly, our directors and executive officers, whether acting alone or together, may have significant influence in determining the outcome of any corporate transaction or other matter submitted to our Board for approval, including issuing common and preferred stock, appointing officers, which could have a material impact on mergers, acquisitions, consolidations and the sale of all or substantially all of our assets, and the power to prevent or cause a change in control. The interests of these board members may differ from the interests of the other stockholders.


Our share ownership is concentrated:


The Company's officers, directors and principal stockholders, together with their affiliates, beneficially own approximately 70% of the Company's voting shares. As a result, these stockholders, if they act together, will exert significant influence over all matters requiring stockholder approval, including the election and removal of directors, any merger, consolidation or sale of all or substantially all of the assets, as well as any charter amendment and other matters requiring stockholder approval. In addition, these stockholders may dictate the day to day management of the business. This concentration of ownership may delay or prevent a change in control and may have a negative impact on the market price of the Company's common stock by discouraging third party investors. In addition, the interests of these stockholders may not always coincide with the interests of the Company's other stockholders.


We may change our investment policies without further shareholder approval:


Although we are limited by the Investment Company Act of 1940 with respect to the percentage of our assets that must be invested in qualified investment companies, we are not limited with respect to the minimum standard that any investment company must meet, neither are we limited to the industries in which those investment companies must operate. We may make investments without shareholder approval and such investments may deviate significantly from our historic operations. Any change in our investment policy or selection of investments could adversely affect our stock price, liquidity, and the ability of our shareholders to sell their stock.


The Company's common stock may be subject to the penny stock rules which might make it harder for stockholders to sell:


As a result of our stock price, our shares are subject to the penny stock rules. Because a "penny stock" is, generally speaking, one selling for less than $5.00 per share, the Company's common stock may be subject to the foregoing rules. The application of the penny stock rules may affect stockholders' ability to sell their shares because some broker-dealers may not be willing to make a market in the Company's common stock because of the burdens imposed upon them by the penny stock rules which include but are not limited to:


     Section 15(g) of the Securities Exchange Act of 1934 and SEC Rules 15g-1 through 15g-6, which impose additional sales practice requirements on broker-dealers who sell Company securities to persons other than established customers and accredited investors.


     Rule 15g-2 declares unlawful any broker-dealer transactions in penny stocks unless the broker-dealer has first provided to the customer a standardized disclosure document.


     Rule 15g-3 provides that it is unlawful for a broker-dealer to engage in a penny stock transaction unless the broker-dealer first discloses and subsequently confirms to the customer the current quotation prices or similar market information concerning the penny stock in question.

 

     Rule 15g-4 prohibits broker-dealers from completing penny stock transactions for a customer unless the broker-dealer first discloses to the customer the amount of compensation or other remuneration received as a result of the penny stock transaction.

 

     Rule 15g-5 requires that a broker-dealer executing a penny stock transaction, other than one exempt under Rule 15g-1, disclose to its customer, at the time of or prior to the transaction, information about the sales persons compensation.


Potential shareholders of the Company should also be aware that, according to SEC Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (i) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii) "boiler room" practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (iv) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (v) the wholesale dumping of the same securities by promoters and broker dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses.


Limited regulatory oversight may require potential investors to fend for themselves:


The Company has elected to be treated as a business development company under the 1940 Act which makes the Company exempt from some provisions of that statute. The Company is not registered as a broker-dealer or investment advisor because the nature of its proposed activities does not require it to do so; moreover it is not registered as a commodity pool operator under the Commodity Exchange Act, based on its intention not to trade commodities or financial futures. However, the Company is a reporting company under the Securities Exchange Act of 1934. As a result of this limited regulatory oversight, the Company is not subject to certain operating limitations, capital requirements, or reporting obligations that might otherwise apply and investors may be left to fend for themselves.

 

The Company's concentration of portfolio company securities:


The Company will attempt to hold the securities of several different portfolio companies. However, a significant amount of the Company's holdings could be concentrated in the securities of only a few companies. This risk is particularly acute during this time period of early Company's operations, which could result in significant concentration with respect to a particular issuer or industry. The concentration of the Company's portfolio in any one issuer or industry would subject the Company to a greater degree of risk with respect to the failure of one or a few issuers or with respect to economic downturns in such industry than would be the case with a more diversified portfolio. At December 31, 2013, 98% of the Company's asset value resulted from a single portfolio holding.


The unlikelihood of cash distributions:


Although the Company has the corporate power to make cash distributions or dividends to shareholders, such distributions are not among the Company's objectives. Consequently, management does not expect to make any cash distributions in the immediate future.


Because many of the Company's portfolio securities will be recorded at values as determined in good faith by the Board of Directors, the prices at which the Company is able to dispose of these holdings may differ from their respective recorded values:


The Company values its portfolio securities at fair value as determined in good faith by the Board of Directors and market prices to the extent necessary to reflect significant events affecting the value of such securities. The Board of Directors may retain an independent valuation firm to aid it on a selective basis in making fair value determinations. The types of factors that may be considered in fair value pricing of an investment include the markets in which the portfolio company does business, comparison of the portfolio company to (other) publicly traded companies, discounted cash flow of the portfolio company, and other relevant factors.


Because such valuations are inherently uncertain, they may fluctuate during short periods of time, and may be based on estimates. Determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. As a result, the Company may not be able to dispose of its holdings at a price equal to or greater than the determined fair value. Net asset value could be adversely affected if the determination regarding the fair value of Company investments is materially higher than the values ultimately realized upon the disposal of such securities.



The lack of liquidity in the Company's portfolio securities would probably prevent the Company from disposing of them at opportune times and prices, which may cause a loss and/or reduce again:


The Company will frequently hold securities in privately held companies. Some of these securities will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of such investments may make it difficult to sell such investments at advantageous times and prices or in a timely manner. In addition, if the Company is required to liquidate all or a portion of its portfolio quickly, it may realize significantly less than the values recorded for such investments. The Company may also face other restrictions on its ability to liquidate an investment in a portfolio company to the extent that the Company has material non-public information regarding such portfolio company. If the Company is unable to sell its assets at opportune times, it might suffer a loss and/or reduce a gain. Restrictions on resale and limited liquidity are both factors the Board will consider in determining fair value of portfolio securities. Moreover, even holdings in publicly-traded securities are likely to be relatively illiquid because the market for companies of the type in which the Company invests tend to be thin and usually cannot accommodate large volume trades.

 

Holding securities of privately held companies may be riskier than holding securities of publicly traded companies due to the lack of available public information:


The Company may hold securities in privately-held companies subject to higher risk than holdings in publicly traded companies. Generally, little public information exists about privately held companies, and the Company will be required to rely on the ability of management to obtain adequate information to evaluate the potential risks and returns involved in investing in these companies. If the Company is unable to uncover all material information about these companies, it may not make a fully informed investment decision, and it may lose some or all of the money it invests in these companies. These factors could subject the Company to greater risk than holding securities in publicly traded companies and negatively affect investment returns.


The market values of publicly traded portfolio companies are likely to be extremely volatile:


Our clients tend to be early stage biotech companies. As a result, their operations and futures are highly dependent on their ability to develop products and successfully bring them to the marketplace. Unlike more seasoned companies with historical financial projections that can be used to evaluate performance, our clients typically do not possess such historical figures. Accordingly, the publically traded shares of our portfolio companies will generally be thinly traded and may be subject to volatile swings in value.


Item 1B. UNRESOLVED STAFF COMMENTS

N/A


Item 2.  PROPERTIES


The Company does not own any real estate or other physical properties materially important to our operation. Our offices are located at 10002 E. Calle De Las Brisas, Scottsdale, AZ  85255. The primary purpose of our office is to have a physical location at which to receive mail. Our part-time employee and consultants work from virtual offices. We believe the use of virtual offices will be adequate for our present business needs.


Item 3. LEGAL PROCEEDINGS


As of the date of this annual report and subsequent events, there are no material pending legal or governmental proceedings relating to our company or properties to which we are a party, and to our knowledge there are no other material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.

 

Item 4. MINE SAFETY DISCLSOURES

Not applicable.

                                  PART II


Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDERS MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES


Market Information  


Our common stock is currently traded on the Over the Counter Pink Sheets under the symbol RONE where we expect it to remain in the foreseeable future. Broker-dealers often decline to trade in OTC Pink Sheet stocks given the markets for such securities are often limited, the stocks are more volatile, and the risk to investors is greater. These factors may reduce the potential market for our common stock by reducing the number of potential investors. This may make it more difficult for investors in our common stock to sell shares to third parties or to otherwise dispose of their shares. This could cause our stock price to decline.



         Quarter Ending          Quarterly High  Quarterly Low


   Dec. 31, 2013              $ 0.06          $0.04

         Sep. 30, 2013              $ 0.05          $0.03

         Jun. 30, 2013              $ 0.11          $0.04

         Mar. 31, 2013              $ 0.09          $0.05


   Dec. 31, 2012              $ 0.25          $0.02

         Sep. 30, 2012              $ 0.10          $0.04

         Jun. 30, 2012              $ 0.09          $0.04

         Mar. 31, 2012              $ 0.09          $0.04

         

   Dec. 31, 2011              $ 0.06          $0.06

         Sep. 30, 2011              $ 0.06          $0.06

         Jun. 30, 2011              $ 0.15          $0.15

         Mar. 31, 2011              $ 0.08          $0.08


         Dec. 31, 2010              $ 0.06          $0.03

         Sep. 30, 2010              $ 0.06          $0.03

         Jun. 30, 2010              $ 0.10          $0.06

         Mar. 31, 2010              $ 0.10          $0.03



Notwithstanding the forgoing, our common stock is sporadically and thinly trading. Accordingly, although there appears to be quotation information, the Company does not believe that there exists an established public market for our securities. Further, there can be no assurance the current market for the Company's common stock will be sustained or grow in the future.

 

Holders of record


As of March 31, 2014, there were:

     621 shareholders of our common stock; and

     5 shareholders of our preferred stock.


The Company feels the actual number of common stock holders may be significantly higher as 2,386,067 common shares are held in street name which is 65.7% of the total common shares outstanding.



Recent Sales of Unregistered Securities


Except as otherwise noted, the securities described were issued pursuant to the exemption from registration provided by Section 4(2) of the Securities Act of 1933. Each such issuance was made pursuant to individual contracts, which are discrete from one another and are made only with persons who had knowledge of and access to sufficient information about the Company to make an informed investment decision and were sophisticated in such transactions. No commissions were paid in connection with the transactions described below unless specifically noted. The information relates as to all securities of the Company sold by the Company within the past three years which were not registered under the Securities Act. Including sales of reacquired securities, as well as new issues, securities issued in exchange for property, services, or other securities, and new securities resulting from the modification of outstanding securities:


There were no sales of Regal One Corporation unregistered securities in 2013 or 2012.


EQUITY COMPENSATION PLAN INFORMATION


1995 Employee & Consultant Incentive Benefit Plan

 

Our board of directors adopted the 1995 Employee & Consultant Incentive Benefit Plan ("1995 Stock Plan") on May 3, 1995, and it was subsequently approved by our stockholders. The 1995 Stock Plan provided for the grant of stock options or stock to our employees, directors, and consultants. The 1995 Stock Plan originally provided for the issuance of 3,000,000 shares of which 2,019,014 are issued and outstanding. As of December 31, 2013, there were no outstanding options to purchase any additional shares under the plan as the plan has been cancelled.








Item 6. SELECTED FINANCIAL DATA


Financial Position as of December 31:


                        2013        2012       2011        2010       2009

                     --------------------------------------------------------

Total assets          $1,162,686  $467,401  $460,662  $1,521,219  $1,676,604

 

Total liabilities        137,193   149,899    91,020      19,465      41,138

 

Net assets            $1,025,493  $317,502  $369,642  $1,501,754  $1,635,466

 

Net asset value per

  outstanding share       $0.282    $0.087    $0.102      $0.413      $0.450


Common shares

outstanding            3,633,067  3,633,067  3,633,067  3,633,067  3,633,067




Operating Data for the last five fiscal years ended December 31:


 

                           2013        2012       2011       2010      2009

                     ------------------------------------------------------

Total investment income         -         -          -          -         -

Total expenses           $111,791     122,173    127,996   165,936  299,012

Payable settlement gain           -         -          -    63,484        -

                         ---------------------------------------------------


Net investment loss      ($111,790)  (122,173)  (127,996) (165,936)(299,012)


 

Stock dividends                 $-        $-        $600        $-      $-


 






















Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


The following information should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this Form 10-K.


Overview


We are a financial services company which coaches and assists biomedical companies through the use of our network of professionals in listing their securities on over the counter or national exchanges. Typically these services are provided to early stage biomedical companies who can benefit from our network of professionals and other partners. As a result of our clients' early stage of development, they typically have limited resources and compensate us for our services in capital stock. Accordingly, although our primary business is to provide consulting services and not to be engaged, directly or through wholly-owned subsidiaries, in the business of investing, reinvesting, owning, holding or trading in securities, we may nonetheless be considered an investment company as that term is defined in the Investment Company Act of 1940 (1940 Act). In order to lessen the regulatory restrictions associated with the requirements of the 1940 Act, on June 16, 2005 we elected to be treated as a Business Development Company (BDC) in accordance with sections 55 through 65 of the 1940 Act. Results reported prior to 2005 are based on prior operations.


Managerial Assistance


As a business development company we will offer and provide upon request managerial assistance to certain of our portfolio companies.  As defined under the 1940 Act, managerial assistance means providing "significant guidance and counsel concerning the management, operations, or business objectives and policies of a portfolio company."  


Financial Condition Overview


The Company's total assets were $1,162,686 and its net assets were $1,025,493 at December 31, 2013, compared to $467,401 and $317,502 at December 31, 2012. In 2013 the Company had a net increase in Net Assets resulting from operations of $707,991 including a $819,782 gain from investing activities offset by a loss of $111,791 in operating expense. The increase was mainly attributable to the unrealized gains in our stock investment and warrants during 2013. Net investment loss (total operating expenses) decreased by $9,903 compared to 2012.


During 2013 the Company realized a net gain of $115,054 on the sale of investment securities and also had an unrealized appreciation on its investment portfolio of $310,528. The Company sold 70,000 shares of portfolio stock at an investment cost of $3,004. The Company also booked an unrealized gain of $394,200 due to the change in the fair value of the stock warrants.


During 2013 the Company decreased liabilities by $12,706 which was primarily a result of a decrease in a note payable with a related party.


The Company's unrealized appreciation (depreciation) on investments varies significantly from period to period as a result of the wide fluctuations in value of the Company's portfolio securities. Our financial condition is dependent on a number of factors including the ability of each portfolio company to effectuate its respective strategies with the Company's help. These businesses are frequently thinly capitalized, unproven, small companies that may lack management depth, and may be dependent on new or commercially unproven technologies, and may have limited operating history.


The Company has incurred losses since its inception and, as a result, has an accumulated deficit of $8,051,800 at December 31, 2013. The net investment loss from operations was reduced to $111,791 for the year ended December 31, 2013 compared to a net investment loss of $122,173 for the same period last year. These factors raise substantial doubt about the Companys ability to continue as a going concern.


The Companys ability to continue as a going concern depends upon its ability to liquidate investments as needed and obtaining sufficient financing to maintain adequate liquidity until such time as operations produce positive cash flow. However, there can be no assurance these actions will be successful.


The accompanying financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. The financial statements do not include any adjustments that might result if the Company was forced to discontinue its operations.



Result of Operations for the twelve month periods ending December 31, 2013 and 2012


Investment Income


We anticipate generating revenue in the form of capital gains or losses on equity securities that we acquire in portfolio companies and subsequently sell. Potentially, we also anticipate receiving dividend income on any common or preferred stock that we own should a dividend be declared. The Company did not have any investment income from operations during 2013 or 2012.


Net realized and unrealized gain (loss) on investments, net for the twelve months ended December 31, 2013 was a gain of $819,782 and a gain of $70,033, respectively for the twelve months ended December 31, 2012. The significant gain during 2013 was primarily related to the increase in the share price of Neuralstem, Inc.


Operating Expenses and Net Investment Income/(Loss)


Our operating expenses consist mostly of fees paid to outside attorneys, consultants, and accountants in connection with the advisory services we provide our clients and to a lesser extent for general overhead. The Company has not received any direct investment income. Net realized gain on portfolio investments sold and the net unrealized appreciation (depreciation) in the value of its portfolio investments and stock options are not included in Net Investment Income but are included in the net increase in net assets resulting from operations. Unrealized gains are not recognized for income tax purposes.


For the year ended December 31, 2013, Total Operating Expenses and Net Investment Loss was $111,791 compared to $122,173 for the year ended December 31, 2012. The decrease of $10,382 in Net Investment Loss as compared to 2012 is primarily attributable to decreases in legal expenses. The 2013 operating expenses consisted primarily of insurance expense, professional services and consulting fees.


The Company plans to decrease its operational expenses in 2014 if no more companies are added to our portfolio. Insurance and interest expense costs will be reduced. Regal has been selling securities in our investment portfolio to finance our operations.


Liquidity and Capital Resources


At December 31, 2013, we had $1,162,686 in assets consisting of: $22,771 in cash and $1,139,915 in investments. Included in investments is $14,615 in liquid money market funds in our investment accounts.


For the twelve month period ended December 31, 2013, we satisfied our working capital needs from cash on hand at the beginning of the period and the net proceeds from the sale of marketable securities in the amount of $115,054. As of December 31, 2013, the Company's net asset value (Equity) was $1,025,493.


From inception, the Company has relied on the infusion of capital through capital share transactions and loans. The Company plans to either: (i) dispose of its current portfolio securities to meet operational needs; or (ii) borrow against such securities via a traditional margin account or other such credit facility. Any such dispositions may have to be made at inopportune times and there is no assurance that, in light of the lack of liquidity in such shares, they could be sold at all, or if sold, could bring values approximating the estimates of fair value set forth in the Company financial statements. Additionally, in the event the Company enters into a margin agreement with regard to any portfolio securities, a decrease in their market value may result in a liquidation of such securities which could greatly depress the value of such securities in the market.


Because our revenues, if generated, tend to be in the form of unrealized gains on our investment portfolio securities, such revenues are not of a type capable of being used to satisfy the Company's ongoing monthly expenses. Consequently, for us to be able to avoid having to defer expenses or sell portfolio companies' securities to raise cash to pay operating expenses, we are constantly seeking to secure adequate funding under acceptable terms. There is no assurance that the Company will be able to do so. Further, if the Company is unable to secure adequate funding under acceptable terms, there is substantial doubt that the Company can continue as a going concern.


Contractual Obligations


                                   Less than   1-3     3-5     More than

                            Total   1 year    years   years     5 years

Loan Payable Officer      $13,000          $13,000      -          -


The Company did not renew its D & O insurance policy in October in which the premiums were financed.


Significant Accounting Estimates and Critical Accounting Policies

 

Our financial statements are prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP"), which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Critical accounting policies are those that require the application of management's most difficult, subjective, or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain and that may change in subsequent periods. In preparing the financial statements, management has made estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. In preparing the financial statements, management has utilized available information, including our past history, industry standards and the current economic environment, among other factors, in forming its estimates and judgments, giving due consideration to materiality. Actual results may differ from these estimates. In addition, other companies may utilize different estimates, which may impact the comparability of our results of operations to those of companies in similar businesses. As our expected operating plans occur we will describe additional critical accounting policies in the notes to our financial statements in addition to those discussed below.


Set forth below is a summary of the significant accounting estimates and critical accounting policies that management believes are important to the preparation of our financial statements. Certain of our accounting estimates are particularly important for an understanding of our financial position and results of operations and require the application of significant judgment by our management. As a result, these estimates are subject to a degree of uncertainty. These significant accounting estimates include:


Valuation of Portfolio Investments


At December 31, 2013, the Company owned 210,000 common shares of Neuralstem, Inc. held as an investment. These shares had a valuation of $611,100 based on the closing market price of the stock. 70,000 shares were sold in 2013 to finance Company operations. 147,500 of these shares are not restricted and are freely tradable with 62,500 shares being restricted as they are held as collateral for a note payable to a related party. The collateral shares will be released when the note is paid.


Regal One also has one ten year warrant for 1,000,000 common shares of Neuralstem at an exercise price of $5 per share which is significantly above the present fair market value of Neuralstem shares. There is currently no market for these Neuralstem stock options. The price of the publicly traded common stock is used as a significant input in the valuation process.


Using a Black-Scholes Option Pricing model, a $513,000 value has been assigned to this warrant as of December 31, 2013 including a 10% discount assigned by management due to low trading volume of Neuralstem common stock. The Company recorded a $394,200 unrealized gain on the stock option investment in 2013 due to the increase in the fair value as determined by the Black-Scholes model.


The Board of Directors is responsible for determining in good faith the fair value of the securities and assets held by the Company. The Investment Committee of the Board of Directors has adopted provisions for valuation of the portfolio as described in Note 1 under Fair Value Accounting through ASC 820. The Investment Committee bases its determination on, among other things, applicable quantitative and qualitative factors. These factors may include, but are not limited to, the type of securities, the nature of the business of the portfolio company, the marketability of and the valuation of securities of publicly traded companies in the same or similar industries, current financial conditions and operating results of the portfolio company, sales and earnings growth of the portfolio company, operating revenues of the portfolio company, competitive conditions, and current and prospective conditions in the overall stock market. Without a readily recognized market value, the estimated value of some portfolio securities may differ significantly from the values that would be placed on the portfolio if there was a ready market for such equity securities.



Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Our business activities contain high elements of risk. The Company considers a principal type of market risk to be a valuation risk. All assets are valued at fair value as determined in good faith by or under the direction of the Board of Directors (which is based, in part, on quoted market prices of similar investments).


Market prices of common equity securities in general, are subject to fluctuations which could cause the amount to be realized upon sale to differ significantly from the current reported value.  The fluctuations may result from perceived changes in the underlying economic characteristics of the Company's portfolio companies, the relative prices of alternative investments, general market conditions and supply and demand imbalances for a particular security.

 

Neither the Company's investments nor an investment in the Company is intended to constitute a balanced investment program. The Company will be subject to exposure in the public-market pricing and the risks inherent therein. For a further discussion of the risk associated with the Company, please refer to the section of this annual report entitled "Risk Factors".

 

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA


The financial statements for Regal One Corporation are annexed in PART IV of this report.
















Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE


None.



Item 9A. CONTROLS AND PROCEDURES


(a) Evaluation of Disclosure Controls and Procedures


The Company's management, under the direction, supervision, and involvement of the Chief Executive Officer and Chief Financial Officer, has carried out an evaluation, as of the end of the period covered by this report, of the effectiveness of the design and operation of the disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act") of the Company. Based on this evaluation, the Chief Executive Officer has concluded that disclosure controls and procedures in place at the Company are not effective to ensure that information required to be disclosed in the Company's Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to the Company's management to allow timely decisions regarding required disclosure based closely on the definition of "disclosure controls and procedures" in Rule 13a-15(e) and 15d-15(e) under the Exchange Act.


(b) Management's Report on Internal Control Over Financial Reporting.


The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Under the direction, supervision and participation of the Company's management, including our Chief Executive Officer and principal financial officer, the Company's management conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992) ("COSO-Framework"). Based on the results of this evaluation under the COSO Framework, management has concluded that its internal control over financial reporting was not effective as of December 31, 2013.


The Company has not established adequate financial reporting monitoring activities to mitigate the risk of management override. Specifically, there is a lack of segregation of duties as there is only one officer/employee overseeing the finance department.


This annual report does not include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to temporary rules for non-accelerated filers by the Securities and Exchange Commission permitting the company to provide only management's report in this annual report.


Changes in Internal Control over Financial Reporting


There has been no change in our internal controls over financial reporting that occurred during the period covered by this Annual Report on Form 10-K that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.


Item 9B. OTHER INFORMATION


Compensatory Arrangements of Certain Officers


No stock options were issued or stock grants granted during fiscal year 2012. Regal's Chief Executive Officer did not receive any salary or other compensation other than direct expense reimbursements.


Departure of Directors or Certain Officers


None in 2013.









                                   PART III

 

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth the name, age and position of each of our directors, executive officers and significant employees as of December 31, 2013. Except as noted below each director will hold office until the next annual meeting of our stockholders or until his or her successor has been elected and qualified. Our executive officers are appointed by, and serve at the discretion of, the Board of Directors.

 

Name                      Age     Current Position            Position

                                                             Held Since

Charles J. Newman          68     Chairman of the Board,

                                  CEO, CFO, Secretary,

                                  Treasurer, and Director        2008


Dr. Malcolm Currie         86     Director                       1995


Bernard L. Brodkorb        72     Director                       2009


Christopher H. Dieterich   66     Director                       2013


CHARLES J. NEWMAN is the present Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Secretary, and Treasurer appointed on June 16, 2008. Mr. Newman is a private investor with corporate management experience. From 1982 to the present, Mr. Newman has been serving as Chief Executive Officer of NCJ Corporation from 1985 to the present. Mr. Newman has been serving as the Chief Executive Officer of Mid America Venture Capital Fund, Inc. Mr. Newman has been serving since 1988 as the Chief Financial Officer of Lincoln Loan and Finance Corporation, National Acceptance Corporation and Ambassador Finance Co., Inc. and Director of Mid America Capital Corp. Since 1992 Mr. Newman has served as the President and Director of the Max and Gertrude Newman - Charles and Phyllis Newman Foundation, a 501(C)(3) charitable foundation. From 2000 to the present, Mr. Newman has served as Vice-President and Director of Doubletree Capital Partners, LLC. He is also a Director of North Central Capital Corporation.


DR. MALCOLM CURRIE was appointed as Chairman of the Board of Directors in 1995 and CEO, CFO of the Company in August 2001 and served in those capacities until June 16, 2008. He remains in his position as Director. From 1969 to 1973, Dr. Currie was the Undersecretary of Research and Engineering for the Office of Defense. From 1973 to 1977, Dr. Currie was President of the Missile Systems Group for Hughes Aircraft Corporation. From 1977 to 1988, Dr. Currie started as Executive Vice President and eventually became Chief Executive Officer and Chairman of the Board of Hughes Aircraft Corporation. From 1992 to present, Dr. Currie has been Chairman Emeritus of Hughes Aircraft Corporation. Dr. Currie is also on the Board of Directors of Innovative Micro Technology, Inc. Dr. Currie obtained a graduate MBA from the University of California, Berkeley, and a PhD in Engineering and Physics at the University of California, Berkeley.


BERNARD L. BRODKORB was appointed to the Board of Directors on February 1, 2009. Mr. Brodkorb served on the Board of directors of ISA Internationale, Inc. (ISAT), a public company, from October 1997 to July 2000 and has been Chairman of the Board of Directors, President, Chief Executive Officer, and Chief Financial Officer of ISAT from February 2001 to present. Mr. Brodkorb is a practicing licensed Certified Public Accountant (CPA) within the State of Minnesota for many years, and has extensive experience in financial and accounting matters relating to both private and public companies, including auditing, financial consulting, and advising on corporate taxation. He is a member of the Minnesota Society of Certified Public Accountants and the American Institute of Certified Public Accountants.



CHRISTOPHER H. DIETERICH is the founder and managing partner of Dieterich & Associates, a litigation and commercial law firm based in Los Angeles, California, providing legal services to entrepreneurial and emerging technology companies during the past 33 years. His firm specializes in venture capital and private equity financings, as well as in SEC compliance issues for public companies. He obtained his undergraduate engineering degree from Virginia Tech, graduate engineering degree from UC Berkeley (1970) and graduated from the joint Law and Economics program at UCLA in 1979, after serving six years in the US Air Force as a flight instructor in advanced jets. He has been an officer and director of Strategic Environmental, a reporting company, since 2008, working on expanding the reach of the Paragon CoronaLux systems. Mr. Dieterich was chosen as a Director because of his experience in a broad range of businesses as well experience serving on the boards of directors and committees of private entities. He receives no salary from the Company.


BOARD AND COMMITTEE MEETINGS


During the Company's fiscal year ending December 31, 2013, the Board of Directors held a total of two meetings and approved no Actions by Written Consent. During that time, no incumbent Director attended fewer than 75% of the aggregate of the total number of meetings of the Board of Directors (held during the period for which he has been a Director).


There are currently no committees of the Board of Directors as the Company does not have sufficient members on the Board that would be classified as independent members. Management is committed to finding additional appropriate knowledgeable independent Board members to assist in the growth of the Company and sit on various board committees. Prior to the establishment of an Audit and Compensation Committee, the entire Board of Directors will perform the functions to be assigned to this committee.



Item 11. EXECUTIVE AND DIRECTOR COMPENSATION


For the year ended December 31, 2013 there was no executive or director compensation. Two directors received consulting fees for work performed not related to being a director.


INDEMNIFICATION


As permitted by the provisions of the General Corporation Law of the State of Florida, the Company has the power to indemnify any officer or director who was or is a party to or threatens to become a party to any threatened, pending or completed action, suit or proceeding whether civil, criminal, administrative or investigative, by reason of the fact that the officer or director of the corporation acted in good faith and in a manner reasonably believed to be in or not opposed to the best interest of the Company.  Any such person may be indemnified against expenses, including attorneys' fees, judgments, fines and settlements in defense of any action, suit or proceeding.



EXCHANGE ACT SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE


Section 16(a) of the Securities Exchange Act of 1934 requires our executive officers, directors, and persons who own more than ten percent (10%) of a registered class of our equity securities to file an initial report of ownership on Form 3 and changes in ownership on Form 4 or 5 with the Securities and Exchange Commission (the "SEC"). Such officers, directors and ten percent (10%) shareholders are also required by the SEC rules to furnish us with copies of all Section 16(a) forms they file.


In 2013 Charles J. Newman filed a periodic Statement of Changes in Beneficial Ownership on Form 4. Based solely on review of copies of such forms received by the Company, or written representations from certain reporting persons that no Forms 5 were required, we believe its executive officers, directors and ten percent (10%) shareholders complied with all Section 16(a) filing requirements applicable to them through the fiscal year ended December 31, 2013.


EXECUTIVE AND DIRECTOR COMPENSATION


OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END


At the end of fiscal year 2013, there were no outstanding equity awards, unexercised stock options, or equity incentive plan awards vested or not vested due to Company Officers or outside consultants.


SUMMARY NON-EMPLOYEE DIRECTOR COMPENSATION TABLE

 

The following table summarizes the compensation for our non-employee board of directors for the fiscal year ended December 31, 2013:  


            Fees                              Nonqualified

           Earned                  Non-Equity   Deferred       All

          Or paid     Stock Option Incentive   Compensation   Other

Name      in Cash    Awards Awards Compensation  Earnings  Compensation Total

----------------------------------------------------------------------------

Brodkorb    $0          0      0          0          0           0       0

Currie      $0          0      0          0          0           0       0

Newman      $0          0      0          0          0           0       0

Dieterich   $0          0      0          0          0           0       0



No additional Director compensation has been authorized for services for the period from January 1, through December 31, 2013 and through the date of this Form 10-K report filing.


Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS


The following table sets forth information, to the best knowledge of the Company, as of March 29, 2014 with respect to each person known by us to own beneficially more than 5% of the outstanding Common Stock, each director and officer, and all directors and officers as a group.


Name and Address                   Common Share          Percent of

of                                 Equivalents          Common Share

Beneficial owner                beneficially owned   Equivalents owned (1)


Charles J. Newman, Officer and Director

P.O. Box 25610

Scottsdale, AZ 85255                     2,234,300           16.39%


Malcolm Currie, Director (2)

11300 W. Olympic Blvd., Suite 800

Los Angeles, California 90064            2,024,200           14.85%


C.B. Family Trust (Richard Babbitt)(3)

10104 Empyrean Way

Los Angeles, California 90067            1,400,000           10.27%


AB Investments LLC (4)

Rodney Unger, Managing Partner

4235 Cornell Road

Agoura, CA 91301                         3,841,500           28.18%


Aaron Grunfeld (5)

10390 Santa Monica Blvd., 4th Floor

Los Angeles, CA 90025-5057               1,200,000            8.80%


Bernard L. Brodkorb, Director

2560 Rice Street

Saint Paul, MN 55113                        47,000            0.34%


All Officers and Directors as a Group    4,305,550           31.58%

 

(1) Includes (i) 3,633,067 shares of common stock issued and outstanding as of December 31, 2013, and (ii) 10,000,000 maximum common shares upon the conversion of the Series B preferred class, and totals to 13,633,067 fully diluted common share equivalents outstanding.  Each share of Preferred Stock is convertible into 100 shares of voting common stock. Of the Preferred Stock outstanding, 30,585 shares (30.6%) are held by a Director of the Company (Dr. Malcolm Currie, 20,242 shares and Charles Newman, 10,343 shares).


(2) 20,242 Series B preferred shares convertible into 2,024,200 common shares.

(3) 14,000 Series B preferred shares convertible into 1,400,000 common shares.

(4) 38,415 Series B preferred shares convertible into 3,841,500 common shares.

(5) 12,000 Series B preferred shares convertible into 1,200,000 common shares.

                                 

Item 13. TRANSACTIONS AND BUSINESS RELATIONSHIPS WITH MANAGEMENT AND PRINCIPAL SHAREHOLDERS


The Board has adopted a policy relating to the approval of transactions with related persons that are required to be disclosed in statements by SEC regulations, which are commonly referred to as "Related Person Transactions." A "related person" is defined under the applicable SEC regulation and includes our directors, executive officers and 5% or more beneficial owners of our common stock. The Board administers the procedures with regards to related person transactions. Approval of a related person transaction requires the affirmative vote of the majority of disinterested directors. In approving any related person transaction, the disinterested directors must determine that the transaction is fair and reasonable to the Company.


Summarized below are certain transactions and business relationships between Regal One Corporation and persons who are or were an executive officer, director or holder of more than five percent of any class of our securities during the last two fiscal years:


For the year ended December 31, 2013, Mr. Bernard L. Brodkorb who is a Director of Regal received $56,400 in fee compensation for providing accounting and financial reporting services not related to his duties as a Director of Regal One Corporation and no compensation for being a Director.


Item 14. PRINCIPAL ACCOUNTANTS FEES AND SERVICES


Audit Fees


The aggregate fees billed by the Company's auditors (Boulay PLLP) for the professional services rendered in connection with the audit services of the Company's financial statements for the year ended December 31, 2013 and 2012  was approximately $19,000 and $10,000, respectively.


Audit Related Fees: None


Tax Fees: None


All Other Fees: None



                              PART IV


Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

Exhibits

 

The following exhibits are included as part of this Annual Report on form 10-K. References to "the Company" in this Exhibit List mean Regal One Corporation, a Florida corporation.

 

Exhibit

Number      Description

 

31.1  Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.


  Filed herewith.


32.2  Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C Section 1350.

 

  Filed herewith


Financial Statement Schedules

 

Financial statements required by Item 15 of this form are filed as a separate part of this report following Part IV:

  

  Report of Independent Registered Public Accounting Firm               F-1

  Balance Sheets at December 31, 2013 and at December 31, 2012          F-2

  Statement of Investments as of December 31, 2013                      F-3

  Statement of Investments as of December 31, 2012                      F-4

  Statements of Changes in Net Assets                                   F-5

  Statements of Operations                                              F-6

  Statements of Cash Flows                                              F-7

  Statements of Financial Highlights                                    F-8

  Notes to Financial Statements                                  Pages 41-49


Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements and the notes thereto.







SIGNATURES

 

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Regal One Corporation


By:  

/S/ Charles J. Newman

 

Charles J. Newman

 

Chief Executive Officer, Chief Financial Officer, and

Chairman of the Board


Dated: April 1, 2014


Pursuant to the requirements of the Securities Exchange Act of 1934, this report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


       NAME                           TITLE                      DATE


/s/ Charles J. Newman      Chief Executive Officer,        April 1, 2014

    Charles J. Newman      Chief Financial Officer, and

                           Chairman of the Board


/s/ Malcolm Currie         Director                        April 1, 2014

    Malcolm Currie


/s/ Bernard L. Brodkorb    Director                        April 1, 2014

    Bernard L. Brodkorb


/s/ Christopher Dieterich  Director                        April 1, 2014

    Christopher Dieterich






0




   REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors and

Stockholders of Regal One Corporation

St. Paul, Minnesota


We have audited the accompanying balance sheets, including the schedule of investments, of Regal One Corporation (a Florida Corporation) (the Company) as of December 31, 2013 and 2012, and the related statements of changes in net assets, operations, cash flows, and financial highlights for the years ended December 31, 2013 and 2012. Regal Ones management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the companys internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Regal One Corporation as of December 31, 2013 and 2012, and the results of its operations, its cash flows, and its financial highlights for each of the years in the two year period ended December 31, 2013 in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred recurring losses and recurring negative cash flows from operating activities, and has an accumulated deficit which raises substantial doubt about its ability to continue as a going concern. Managements plans concerning these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.


/s/ Boulay PLLP

Boulay PLLP

Minneapolis, Minnesota

March 31, 2014

                                                                             F-1


REGAL ONE CORPORATION

BALANCE SHEETS


                                                           As of December 31,

                                                        2013                  2012

                                                      

                              ASSETS             -----------------  ------------------

Assets:

   Investments:

     Investments in non-affiliated companies         $   958,040     $        357,447

     Investments in non-affiliated companies

        (Pledged to secure note payable officer)       181,875               68,125

                                                        --------          -----------

    Total investments                                  1,139,915              425,572


   Cash                                                   22,771               19,121

   Prepaid insurance                                           -               22,708

                                                      ----------          -----------

TOTAL ASSETS                                         $ 1,162,686              467,401

                                                      ==========          ===========


                      LIABILITIES


   Accounts payable and accrued liabilities           $   15,800       $       27,550

   Accounts payable related party                      106,850               72,950

   Note payable - officer                                 13,000               47,366

   Accrued interest-notes payable - officer                  943                1,433

   Dividends payable                                         600                  600

                                                      ----------            ---------

        Total liabilities                                137,193              149,899

                                                      ==========          ===========


                       NET ASSETS


Net Assets are comprised of:

   Preferred stock, no par value

      Series A - 50,000 shares authorized, none issued

        or outstanding                                         -                   -

      Series B - 500,000 shares authorized, 100,000

        issued and outstanding at December 31, 2013

        and 2012                                             500                 500

   Common stock, par value $0.001,

     50,000,000 shares authorized; 3,633,067 shares

       issued and outstanding at December 31, 2013

       and 2012                                            3,633                3,633


   Additional paid-in capital                          8,373,060            8,373,060

   Losses and distributions in excess of earnings     (8,416,787)          (8,421,673)

   Cumulative unrealized appreciation on investments   1,065,087              361,982

                                                      -----------          -----------

        Total net assets                               1,025,493              317,502

                                                      -----------           ----------

TOTAL LIABILITIES AND NET ASSETS                      $1,162,686           $  467,401

                                                    ============           ===========


Net asset value per outstanding share of common

   stock                                             $    0.282                 0.087

                                                    ============           ===========



The accompanying notes are an integral part of these condensed financial statements.


                                        F-2



                                  

REGAL ONE CORPORATION

                                SCHEDULE OF INVESTMENTS

                                   December 31, 2013


Equity Investments:

                                                                        

                                                               Fair    Percent

                           Description         Carrying Cost   Market  Ownership

Portfolio Company          of Business         Investment      Value        Affiliation


Neuralstem, Inc.(CUR)      Biomedical company  $  9,013 (1)  $ 611,100     1.0%   No

Neuralstem Warrant         Biomedical company    50,000 (2)    513,000     0.0%   No

LMP Money Market Trust     Money Market Fund     14,615 (3)     14,615     0.0%   No

Rampart Detection Systems  Manufacturing          1,200 (4)      1,200     0.1%   No

                                                 ---------   ---------    -----

Total Investments                              $ 74,828     $1,139,915   



(1) As of December 31, 2013, there were 210,000 Neuralstem shares held reported on a fair value basis valued at the closing market price of $ 2.91 in fair market value applied. 70,000 shares were sold during 2013. 62,500 shares have been pledged as collateral to secure a note payable - officer.


(2) Regal also has a ten year Neuralstem warrant to purchase 1,000,000 common stock shares at an exercise price of $5.00 per share which is above the present fair market value of Neuralstem shares. As of December 31, 2013 using a Black-Scholes Option Pricing Model, a $513,000 value was assigned to these warrants including a 10% discount assigned by management due to the low trading volumes of Neuralstem stock. There is currently no market for Neuralstem warrants carried as an investment.


To calculate the December 31, 2013 value of the Neuralstem warrant, management used the following factors in a Black-Scholes Option Pricing Model:

   Number of shares in warrant:                                        1,000,000

   Date option was issued:                                             9/15/2005

   Remaining term of option in years:                                        1.7

   Neuralstem Common Stock closing price on 12/31/2013:                    $2.91

   Annual volatility:                                                    69.210%

   Discount Rate based on Daily Treasury Bills long term rates on 12/31/13: 1.31%

   Management estimated discount applied to fair market value:             10.0%


(3) The Company had $14,615 in an investment money market fund at 12/31/2013.


(4) Regal purchased common stock valued at $1,200 as an investment in Rampart Detection Systems Ltd.








The accompanying notes are an integral part of these condensed financial statements.





                                          F-3



                             REGAL ONE CORPORATION

                            SCHEDULE OF INVESTMENTS

                               December 31, 2012


Equity Investments:

                                                                       

                                                 Carrying        Fair   Percentage

                             Description           Cost          Market  Ownership

Portfolio Company            of Business         investment      Value      Affiliation


Neuralstem, Inc.(CUR)        Biomedical company $ 12,018 (1)   $305,200    1.0%    No

Neuralstem Warrant           Biomedical company   50,000 (2)    118,800    0.0%    No

LMP Money Market Trust       Money Market Fund       372 (3)        372    0.0%    No

Rampart Detection Systems    Manufacturing         1,200 (4)      1,200    0.1%    No

                                                ---------     ---------    -----

Total Investments                               $ 63,590      $ 425,572      



(1) As of December 31, 2012, there were 280,000 Neuralstem shares held reported on a fair value basis valued at the closing market price of $ 1.09 with no reduction in fair market value applied. 70,500 shares were sold during 2012. 62,500 shares have been classified as Investments in non-affiliated companies Pledged to secure note payable - officer.


(2) Regal also has a ten year Neuralstem warrant to purchase 1,000,000 common stock shares at an exercise price of $5.00 per share which is significantly above the present fair market value of Neuralstem shares. As of December 31, 2012 using a Black-Scholes Option Pricing Model, a $118,800 value was assigned to these warrants including a 10% discount assigned by management due to the low trading volumes of Neuralstem stock. There is currently no active market for the Neuralstem Warrants (stock options) carried as an investment.


To calculate the December 31, 2012 value of the Neuralstem warrant, management used the following factors in a Black-Scholes Option Pricing Model:

   Number of shares in warrant:                                       1,000,000

   Date option was issued:                                            9/15/2005

   Remaining term of option in years:                                       2.7

   Neuralstem Common Stock closing price on 12/31/2012:                    $1.09

   Annual volatility:                                                      75.033%

   Discount Rate based on Daily Treasury Bills long term rates on 12/31/12: 0.25%

   Management estimated discount applied to fair market value:             10.0%


(3) The Company had $372 in a money market fund at 12/31/2012.


(4) Regal purchased common stock valued at $1,200 as an investment in Rampart Detection Systems Ltd.








The accompanying notes are an integral part of these condensed financial statements.



                                         F-4


                          REGAL ONE CORPORATION

                    STATEMENTS OF CHANGES IN NET ASSETS

 


                                              For the        For the   

                                             Year Ended     Year Ended

                                             December 31,   December 31,

                                                2013            2012    

OPERATIONS:                                   ----------    -----------

 

Net investment loss                          $ (111,791)    $ (122,173)

Net realized gain on investments                115,054         76,639

Net change in unrealized appreciation

  (depreciation)of stock investments            310,528        (30,006)

Unrealized appreciation (depreciation)

  of warrant investment                         394,200         23,400

                                             ------------   ----------

Net increase (decrease) in net assets

  resulting from operations                     707,991        (52,140)


SHAREHOLDER ACTIVITY:

  Declared dividend                                   -              -


NET INCREASE (DECREASE) IN NET ASSETS           707,991        (52,140)


NET ASSETS:

     Beginning of period                        317,502        369,642

 

     End of period                            1,025,493        317,502


     Average net assets                       $ 671,498       $343,572


TOTAL NET ASSET VALUE RETURN                     105.4%        (15.2%)

Ratio to average net assets:


     Net investment loss                          16.6%          35.6%















The accompanying notes are an integral part of these condensed financial statements.


                                   F-5



                                    REGAL ONE CORPORATION.

                                  STATEMENTS OF OPERATIONS


                                               For the Years Ended December 31,

                                                      2013           2012  

                                 

               -----------     ----------


Investment income                                 $      --      $      --  


Operating expenses:

 Professional services                               22,400         27,201

 Accounting fees- related party                      56,400         58,650

 Interest expense                                     2,736          3,467

Other selling, general and

    administrative expenses                          30,255         32,805

Income tax expense                                        0             50

                                                   ---------       --------  

    Total operating expenses                        111,791        122,173

                                                   ---------       --------  

Net investment loss                                (111,791)      (122,173)


Realized and unrealized gain (loss) on investments  

  Net realized gain on portfolio investments        115,054         76,639

Net change in unrealized appreciation

  (depreciation)of stock investments          310,528       (30,006)

  Net unrealized appreciation (depreciation)

    in warrant investment                           394,200         23,400

                                                    --------       --------

    Net realized and unrealized gain (loss)

     on investments                                 819,782         70,033

                                                   --------       ---------

  

Net increase (decrease) in net assets

   Resulting from operations                    $   707,991     $  (52,140)

                                                  ==========    ===========  


Per share information:

Weighted average common shares outstanding

        Basic                                     3,633,067      3,633,067

        Diluted (1)                              13,633,067     13,633,067


Net investment loss per share:

        Basic and diluted                         $ (0.031)      $ (0.034)  

                                                 ==========     ===========

Net increase (decrease) in net assets resulting from

  Operations per share:

        Basic                                     $  0.195        (0.014)

        Diluted                                   $  0.052        (0.014)

                                                 ==========     ===========


(1) Includes Series B Preferred Shares convertible at 100 for 1.





The accompanying notes are an integral part of these condensed financial statements.






                                          F-6




REGAL ONE CORPORATION

STATEMENTS OF CASH FLOWS


                                                   For the Years Ended December 31,

                                                            2013          2012

                                                        

                                                   ------------------  ----------

Cash flows from operating activities:

Net decrease in net assets from operations              $  707,991   $  (52,140)

Adjustments to reconcile net decrease

    in net assets from operating activities:

     

Realized gain on sale of marketable securities      (115,054)     (76,639)

Proceeds from sale of investments                    105,437       79,309

Net change in unrealized (appreciation)

Depreciation of stock investments               (310,526)      30,006

Unrealized (increase) in investment in options      (394,200)     (23,400)

      

Changes in operating assets and liabilities:

        Prepaid expense                                     22,708            -

        Accounts payable and accrued expenses              (12,240)       1,950

        Accounts payable Related Party                    33,900       54,150

                                                         ---------      --------

Net cash provided by (used in) operating activities        38,016        13,236


Cash Flows from financing activities:

      Increase (decrease) in officer loans

           and interest payable                            (34,366)       2,779

                                                         ---------      --------  

Net cash provided by financing activities                  (34,366)       2,779

 

Net change in cash                                           3,650       16,015

Cash at beginning of period                                 19,121        3,106

                                                        ----------      --------  

Cash at end of period                                   $   22,771       19,121

                                                       =============  ===========




Cash Paid for interest                                      $2,842           -    










The accompanying notes are an integral part of these condensed financial statements.






                                              F-7





39




                                             REGAL ONE CORPORATION  

                                       STATEMENTS OF FINANCIAL HIGHLIGHTS


                                                  For the Years Ended December 31,

                                                   2013      2012       2011      2010      2009

                                           -----------    --------   -------   --------   --------

    Per Common Share Unit Operating Performance


OPERATIONS:

Net investment loss from operations           $  (0.031)   (0.034)    (0.34)    (0.046)    (0.082)

Net realized gain on portfolio securities         0.032     0.021      0.009     0.018      0.069

Net change in unrealized appreciation

  (depreciation)of stock investments              0.085    (0.008)     0.123     0.019     (0.67)

Net unrealized appreciation

  (depreciation) of option investments            0.109    (0.006)     0.163    (0.046)     0.222

Gain on Legal Expense settlement                                                 0.017

                                               ---------  --------   -------    -------     ------

Net increase (decrease) in net assets

  from operations                                 0.195    (0.014)     0.311    (0.037)     0.142


SHAREHOLDER ACTIVITY

    Declared dividend                                --        --         --         --        --

                                               --------   --------   --------    --------  -------

NET DECREASE IN NET ASSETS                      $ 0.195   $(0.014)     0.311    (0.037)     0.142


NET ASSET VALUE, BEGINNING OF PERIOD              0.087   $ 0.102      0.413     0.450      0.308


NET ASSET VALUE, END OF PERIOD                    0.282   $ 0.087      0.102     0.413      0.450

                                              =========   =======     =======    ======     =====


TOTAL NET ASSET VALUE RETURN (LOSS)             105.4%    (15.2%)      121.0%    (8.5%)     37.4%

                                               =======   ========     =======    =======    ======







                                                        F-8





40



NOTE 1 - NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES


Business


Regal One Corporation (the "Company" or "Regal One"), located in Scottsdale, Arizona, is a Florida corporation initially incorporated in 1959 as Electro-Mechanical Services Inc., in the state of Florida. Since inception we have been involved in a number of industries. In 1998 we changed our name to Regal One Corporation.


On March 7, 2005, our board of directors determined it was in our shareholders' best interest to change the focus of the company's operation to providing financial consulting services through our network of advisors and professionals, and to be treated as a business development company ("BDC") under the Investment Company Act of 1940. On September 16, 2005, we filed a Form N54A (Notification of Election by Business Development Companies), with the Securities and Exchange Commission, which transforms the Company into a Business Development Company (BDC) in accordance with sections 55 through 65 of the Investment Company Act of 1940. The Company has reported as an operating BDC since March 31, 2006.


Accounting Policies


Basis of Presentation


The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, ("U.S. GAAP").


Management Estimates


The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company uses estimates and assumptions in accounting for the following significant matters, among others: the valuation of portfolio investments and the assumptions used as part the going concern analysis. It is at least reasonably possible that these estimates will change in the future. Actual amounts may differ from these estimates, and such differences may be material to the financial statements. The Company periodically reviews estimates and assumptions, and the effects of any such revisions are reflected in the period in which the revision is made.


Valuation of Portfolio Investments


Investments are reported on the balance sheet at fair value. On a quarterly basis the Company performs an analysis of each investment to determine fair market value. Securities for which market quotations are readily available on an exchange are valued at the reported closing price on the valuation date. The Company may also obtain quotes with respect to certain of the Company's investments from pricing services or brokers or dealers in order to value assets. When doing so, the Company determines whether the quote obtained is sufficient according to GAAP to determine the fair value of the security. If determined adequate, the Company uses the quote obtained. The Company uses the Black-Scholes pricing model to determine the fair value of the Companys warrant investments.



Investment Classification


The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, "Control Investments" are defined as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Under the 1940 Act, "Affiliated Investments" are defined as those non-control investments in companies in which the Company owns between 5% and 25% of the voting securities. Under the 1940 Act, "Non-affiliated Investments" are defined as investments that are neither Control Investments nor Affiliated Investments. The Company has no control investments or affiliated investments as defined under the 1940 Act.


Cash and cash equivalents


Cash consists of bank account balances and may include instruments with maturities of three months or less at the time of purchase and cash equivalent balances on deposit with investment brokerage firms. Currently we classified the money market funds on deposit in our investment brokerage account as part of our investments.


Net Decrease in Net Assets from Operations per Share


Basic net decrease in net assets from operations per share is computed by dividing the net decrease in net assets from operations amount adjusted for cumulative dividends on preferred stock (numerator) by the weighted average number of common shares outstanding during the period (denominator). Diluted net increase (decrease) in net assets from operations per share amounts reflect the maximum dilution that would have resulted from the assumed exercise of stock options and from the assumed conversion of the Series B Convertible Preferred Stock. Diluted net decrease in net assets from operations per share is computed by dividing the net decrease in net assets from operations amount adjusted for cumulative dividends on preferred stock by the weighted average number of common and potentially dilutive securities outstanding during the period. For the period ending December 31, 2012 the above potentially dilutive securities are excluded from the computation as their effect is anti-dilutive.


Income Taxes


The Company has not elected to be a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended. Accordingly, the Company will be subject to U.S. federal income taxes on sales of investments for which the fair values are in excess of their tax basis. Income taxes are accounted for using an asset and liability approach for financial reporting. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the financial statement carrying amount and the tax basis of assets and liabilities and net operating loss and tax credit carry forwards. Management has established a valuation allowance to reduce deferred tax assets to the amounts expected to be realized in future years. For years before 2010, the Company is no longer subject to U.S. Federal income tax examinations.


Advertising


The Company expenses advertising costs when incurred. There were no advertising fees incurred during the period.



Net Realized Gains or Losses and Net Change in Unrealized Appreciation or Depreciation


Gains or losses on the sale of investments are calculated using the specific identification method. The Company measures realized gains or losses by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized upfront fees and prepayment penalties. Net change in unrealized appreciation or depreciation will reflect the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation, when gains or losses are realized.


NOTE 2 GOING CONCERN


The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the creation of assets and the liquidation of liabilities in the normal course of business. The Company does not currently generate operating revenue and must liquidate the Company's investment portfolio to provide cash flow for its operations. The Company is actively seeking sources of revenue for its consulting services but does not have contractual obligations now or in the near future to generate revenue. This fact and the declining market value of the portfolio investment stock it owns due to sales of inventory securities and volatile market conditions has raised substantial doubt regarding Regal's ability to continue as a going concern.  In response, management will continue to liquidate assets as necessary while actively searching out new equity investors and continue to rely upon current shareholders to provide loans or additional investment to meet the Companys ongoing obligations. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.




NOTE 3 - FAIR VALUE OF FINANCICAL INSTRUMENTS


ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below:


    Level 1   Unadjusted quoted prices in active markets that are accessible

              at the measurement date for identical, unrestricted assets or

              liabilities;


    Level 2   Quoted prices in markets that are not active, or inputs that

              are observable, either directly or indirectly, for

              substantially the full term of the asset or liability;


    Level 3   Prices or valuation techniques that require inputs that are

              both significant to the fair value measurement and unobservable

              (supported by little or no market activity).


The level in the fair value hierarchy within which a fair measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety.


The carrying value of cash, and accounts payable, note payable officer, and accrued interest approximates fair value due to the short maturity nature of these instruments.


Assets measured at fair value on a recurring basis at December 31, 2013:


                                                               Fair

                              Level of      Carrying Cost     Market

Equity Investments:          Investment      Investment        Value


Neuralstem, Inc.(CUR)          Level 1       $  9,013       $611,100

LMP Money Market Trust Fund    Level 1         14,615         14,615

Rampart Detection Systems      Level 2          1,200          1,200

Neuralstem Warrant             Level 3         50,000        513,000

                                            ---------      ---------

  Total investments                          $ 74,828     $1,139,915



Assets measured at fair value on a recurring basis at December 31, 2012:


                                                               Fair

                              Level of      Carrying Cost     Market

Equity Investments:          Investment      Investment        Value


Neuralstem, Inc.(CUR)          Level 1       $ 12,018       $305,200

LMP Money Market Trust Fund    Level 1            372            372

Rampart Detection Systems      Level 2          1,200          1,200

Neuralstem Warrant             Level 3         50,000        118,800

                                            ---------      ---------

  Total investments                          $ 63,590       $425,572




Assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are:


Beginning balance as of December 31, 2011                $  95,400

Net change in unrealized appreciation

  of warrants in 2012                                       23,400

                                                          ---------

Ending balance as of December 31, 2012                   $ 118,800

Net change in unrealized appreciation

  of warrants in 2013                                      394,200

                                                          ---------

Ending balance as of December 31, 2013                   $ 513,000


The table below presents the inputs used to value the Companys Level 3 financial instruments as of December 31, 2013 using the Black-Scholes Option Pricing Model:

      

 Warrants:              Expected term             1.7 years

                              Risk free rate            1.31%

                              Annual volatility        69.21%

                              Fair value of stock      $2.91 per share

                              Dividend rate               0%

                              Liquidity discount         10%   


Of the inputs noted above, the liquidity discount is an unobservable input.


NOTE 4 - EQUITY TRANSACTIONS


Common Stock


The Company has 50,000,000 shares of common stock, par value $.001, authorized with 3,633,067 issued and outstanding shares. If all outstanding preferred equity were converted the outstanding shares would increase to 13,633,067.


Preferred Stock

 

The Company's Certificate of Incorporation allows for segregating the preferred stock into separate series. As of December 31, 2013, the Company had authorized 50,000,000 shares of total preferred stock; 50,000 shares of Series A preferred stock with no shares outstanding; 500,000 shares of Series B convertible preferred stock were authorized and 100,000 shares of Series B preferred stock were outstanding.


Holders of Series A preferred stock shall be entitled to voting rights equivalent to 1,000 shares of common stock for each share of preferred. The Series A preferred stock has certain dividend and liquidation preferences over common stockholders.


Holders of Series B preferred stock shall be entitled to voting rights equivalent to 100 shares of common stock for each share of preferred. The Series B preferred stock had been entitled to a non-cumulative dividend of 8.75% of revenues which exceed $5,000,000. In 2004, the Series B class shareholders' voted by a large majority to void the dividend preference. At the option of the holder of Series B preferred stock, each share is convertible into common stock at a rate of 100 shares of common for each share of preferred. In connection with the acquisition of O2 Technology on February 9, 2004, the Share Exchange agreement required that the Series B preferred as a class be restricted to a cumulative conversion into no more than 10,000,000 common shares. This reduction was sought by the Company and was agreed to by 98.5% of the Series B class, effecting a compression of the outstanding Series B preferred from 208,965 shares to the now outstanding 100,000 shares. For the years ended December 31, 2013, and 2012, no dividends have been declared on the Series A or Series B convertible preferred stock.


NOTE 5 - INVESTMENTS


Neuralstem, Inc.


At December 31, 2013, the Company owned 210,000 common shares of Neuralstem, Inc. held as an investment. These shares had a valuation of $513,000 based on the closing market price of the stock. 70,000 shares were sold in 2013 to finance Company operations. Regal recorded an unrealized gain of $310,528 in 2013 due to an increase in the price of Neuralstem shares. 147,500 of these shares are not restricted and are freely tradable with 62,500 shares being restricted as they are held as collateral for a note payable to a related party.


Regal One also has one ten year warrant for 1,000,000 common shares of Neuralstem at an exercise price of $5 per share which is significantly above the present fair market value of Neuralstem shares. There is currently no market for these Neuralstem stock Options. The price of the underlying publicly traded common stock is used as a significant input in the valuation process.


As of December 31, 2013, using a Black-Scholes Option Pricing model, a $513,000 value was assigned to this warrant including a 10% discount assigned by management due to low trading volume of Neuralstem common stock. Regal recorded a $394,200 unrealized gain on the investment in 2013 due to increase in the fair value as determined by the Black-Scholes model.


The Board of Directors is responsible for determining in good faith the fair value of the securities and assets held by the Company. The Investment Committee of the Board of Directors has adopted provisions for valuation of the portfolio as described in Note 1 under Fair Value Accounting through ASC 820. The Investment Committee bases its determination on, among other things, applicable quantitative and qualitative factors. These factors may include, but are not limited to, the type of securities, the nature of the business of the portfolio company, the marketability of and the valuation of securities of publicly traded companies in the same or similar industries, current financial conditions and operating results of the portfolio company, sales and earnings growth of the portfolio company, operating revenues of the portfolio company, competitive conditions, and current and prospective conditions in the overall stock market. Without a readily recognized market value, the estimated value of some portfolio securities may differ significantly from the values that would be placed on the portfolio if there was a ready market for such equity securities.


NOTE 6 - INCOME TAXES


The Company has not elected to be a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended. Accordingly, the Company will be subject to U.S. federal income taxes on sales of investments for which the fair values are in excess of their tax basis. Income taxes are accounted for using an asset and liability approach for financial reporting. The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the financial statement carrying amount and the tax basis of assets and liabilities and net operating loss and tax credit carry forwards. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.


At December 31, 2013 and 2012, the Company had a federal operating loss carry forward of $2,605,735 and $2,764,604 respectively. Under IRC Section 172(b)(3), the taxpayer elects to relinquish the entire two year carryback period with respect to any regular tax and AMT net operating loss incurred during the current tax year. Regal became a BDC in June 2005. The deferred tax expires in the periods between 2019 to 2030.


The provision for income taxes consisted of the following components for the years ended December 31, 2013 and 2012:

                                            2013          2012

                                         ---------     ----------  

   Current:

        Federal                             $--           $--

        State                                --            --

   Deferred:                                 --            --  

 

Components of net deferred tax assets, including a valuation allowance, are as follows at December 31:


   Deferred tax assets:                     2013          2012  

                                        ---------      --------

   Net operating loss carry forward    $2,605,735     $2,764,604

                                        ------------   ----------

          Total deferred tax assets     1,115,255     $1,183,251

 

   Less: Valuation allowance           (1,115,255)    (1,183,251)

                                       ------------   -----------

    Net deferred tax assets                  $ -          $    -


FASB authoritative guidance requires that a valuation allowance be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The valuation allowance for deferred tax assets as of December 31, 2013 and 2012 was $1,115,255 and $1,183,251, respectively. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. In assessing the recovery of the deferred tax assets, management considers the scheduled reversals of future deferred tax assets, projected future taxable income, and tax planning strategies in making this assessment. As a result, management determined it was more likely than not the deferred tax assets would not be realized as of December 31, 2013 and 2012. Net Deferred Tax Assets are not presented on our Balance Sheets.


Reconciliation between the statutory rate and the effective tax rate is as follows at December 31:

                                              2013           2012

Federal statutory tax rate                   (34.0)%        (34.0)%

State taxes, net of federal tax benefit  (8.8)%       (8.8)%

Increase in valuation allowance          42.8 %        42.8%

Effective tax rate                          0%            0%



NOTE 7 - RELATED PARTY TRANSACTIONS


For the year ended December 31, 2013 Bernard L. Brodkorb who is a Director of Regal received $56,400 in fee compensation for providing accounting and financial reporting services, of which $22,500 was paid during the year, not related to his duties as a Director of Regal One Corporation and no compensation for his Director duties. In 2012 he received $58,650 for these services and no compensation for being a Director.  As of the year ended December 31, 2013, Bernard L. Brodkorb has a balance owed in accounts payable of $106,850 for services rendered.  There was $72,950 owed in accounts payable due to Bernard L. Brodkorb for services rendered as of December 31, 2012. Dieterich and Associates was owed $10,668 as of December 31, 2012.


The Company has an outstanding note payable due to Charles J. Newman in the amount of $13,000 with accrued interest due of approximately $943 as of December 31, 2013.  The note accrues interest at 6% per annum and is collateralized with 62,500 shares of Neuralstem common stock held as an investment.  The note was due in full with interest at the option of the Company on December 31, 2012.  Although the option to pay in full is upon the Company, these notes are considered to be in default as of the date of this filing.


NOTE 8 - Legal Proceedings


As of the date of this report and subsequent events, there are no material pending legal or governmental proceedings relating to our company or properties to which we are a party, and to our knowledge there are no other material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.




Note 9 - Quarterly Financial Data (Unaudited)


For the year ended December 31, 2013


                               First       Second       Third      Fourth

                              Quarter      Quarter     Quarter    Quarter

                           ----------------------------------------------

Investment income----


Net Loss                     $(29,556)   $(28,459)   $(30,277)  $(23,498)


                              -------------------------------------------

Net increase (decrease) in

 Net assets from operations   (47,719)    115,853     613,176     26,681


Net increase (decrease) in

 Net assets from operations

   Per common share.


     Basic                    (0.0131)     0.0319      0.1688     0.0073

     Diluted                  (0.0131)     0.0085      0.0450     0.0020







For the year ended December 31, 2012


                              First      Second     Third     Fourth

                             Quarter     Quarter   Quarter   Quarter

                           -------------------------------------------


Investment income                --         --          --         --


Net loss from operations    $(37,005)   $(33,773)  $(24,202) $(27,193)


Investment income             59,440    (103,891)   196,328   (81,844)

                             -----------------------------------------

Net increase (decrease) in

 Net assets from operations   21,435    (138,465)   171,377   (106,487


Net increase (decrease) in

 Net assets from operations

   Per common share.     


     Basic                     0.006     (0.038)      0.047    (0.029)

     Diluted                   0.002     (0.038       0.013    (0.029)




End of document




41